TITLE:
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

CONDITION:
Osteoporosis, Postmenopausal

INTERVENTION:
MK0217, alendronate sodium/Duration of Intervention: 12 mo

SUMMARY:

      The purpose of this study and 12 month extension is to evaluate the effects of two
      investigational drugs on osteoporosis in postmenopausal women.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 40 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Postmenopausal women with osteoporosis

        Exclusion Criteria:

          -  Any known allergy to the study drug
      
